Filter
7953
Filtered Results: 7953
Text search:
national
health
target
Featured
Recommendations
636
New Publications
2256
Language
Document type
No document type
4606
Studies & Reports
1400
Guidelines
890
Manuals
354
Strategic & Response Plan
335
Fact sheets
126
Training Material
105
Situation Updates
80
Resource Platforms
22
Infographics
15
Online Courses
10
Brochures
9
Videos
1
Countries / Regions
Global
358
India
331
Kenya
271
Ethiopia
191
Uganda
183
Nepal
171
Nigeria
156
South Africa
153
Sierra Leone
147
Liberia
144
Myanmar / Burma
140
Western and Central Europe
138
Rwanda
130
Zambia
129
Indonesia
123
Malawi
121
Bangladesh
117
Africa
113
Tanzania
106
Ghana
99
Syria
97
Latin America and the Carribbean
94
Ukraine
91
Congo, Democratic Republic of
90
Philippines
79
South Sudan
71
Namibia
68
Cambodia
55
Lesotho
55
South–East Asia Region
55
Senegal
53
Zimbabwe
53
Asia
48
Mozambique
47
Guinea
46
West and Central Africa
45
East and Southern Africa
44
Eastern Europe
43
Haiti
42
Botswana
37
Yemen
37
Middle East and North Africa
36
Pakistan
32
Venezuela
31
Burkina Faso
30
Cameroon
28
Afghanistan
28
Brazil
27
Eastern Europe and Central Asia
25
Germany
23
Sudan
22
Eswatini/ Swaziland
22
Western Pacific Region
22
Somalia
21
Central African Republic
21
Russia
21
Colombia
20
Jordan
19
Lebanon
19
Mali
17
Benin
15
Iraq
14
Thailand
14
China
14
Moldova
14
Sri Lanka
13
Vietnam
13
USA
12
Albania
12
Tajikistan
12
Côte d’Ivoire / Ivory Coast
11
Turkey
10
Paraguay
10
Laos
10
Peru
9
Madagascar
9
Georgia
9
Angola
8
Southern Africa
8
Niger
7
Burundi
7
Libya
7
Chile
7
Palestine
7
Iran
7
Kyrgyzstan
7
North America
7
Togo
6
Egypt
6
Chad
6
Argentina
6
Jamaica
6
Gambia
5
Papua New Guinea
5
North Macedonia
5
Ecuador
5
Timor Leste/ East Timor
5
Kazakhstan
5
Turkmenistan
5
Guinea-Bissau
4
Saudi Arabia
4
Serbia
4
El Salvador
4
Mexico
4
Poland
4
Romania
4
Morocco
3
Hungary
3
Fiji
3
Bhutan
3
Djibouti
3
Armenia
3
Uzbekistan
3
Portugal
3
Bosnia and Herzegovina
3
Malaysia
2
Mauritania
2
Singapore
2
Croatia
2
Honduras
2
Bolivia
2
Greece
2
Guatemala
2
Italy
2
Canada
2
Qatar
2
Bulgaria
2
Estonia
2
Lithuania
2
Gabon
2
Japan
2
Mauritius
2
Tunisia
2
United Kingdom
2
Spain
2
Azerbaijan
2
Ireland
1
Vanuatu
1
Other region
1
North Korea
1
Mongolia
1
Congo-Brazzaville
1
Slovakia
1
Denmark
1
Belgium
1
France
1
Maldives
1
Norway
1
Belarus
1
Israel
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
3196
Clinical Guidelines
517
Public Health
472
Women & Child Health
373
Key Resources
349
Capacity Building
119
Pharmacy & Technologies
75
Protection & Security
2
Annual Report MEDBOX
1
General Guidelines
1
Toolboxes
COVID-19
649
HIV
643
Mental Health
503
TB
380
Disability
305
Planetary Health
297
AMR
261
Conflict
260
Rapid Response
231
Ebola
205
NTDs
190
NCDs
165
Caregiver
154
Global Health Education
135
Refugee
131
Natural Hazards
103
Pharmacy
101
Health Financing Toolbox
94
Polio
51
Cholera
47
Zika
47
Specific Hazards
41
Social Ethics
11
Typhoon
7
South Sudan
2
Health Financing
2
A Guide to the Application of the WHO Multimodal Hand HygieneImprovement Strategy and the “My Five Moments for Hand Hygiene”Αpproach
Molecular methods for antimicrobial resistance (AMR)diagnostics to enhance the Global Antimicrobial Resistance Surveillance System
The WHO CIA List should be used as a reference to help formulate and prioritize risk assessment and risk management strategies for containing antimicrobial resistance. The WHO CIA List supports strategies to mitigate the human health... risks associated with antimicrobial use in food-producing animals and has been used by both public and private sector organizations. The list helps regulators and stakeholders know which types of antimicrobials used in animals present potentially higher risks to human populations and how use of antimicrobials might be managed to minimize antimicrobial resistance of medical importance. The use of the WHO CIA List, in conjunction with the OIE list of antimicrobials of veterinary importance (1) and the WHO Model Lists of Essential Medicines (2) , will allow for prioritization of risk management strategies in the human sector, the food animal sector, inagriculture (crops) and horticulture, through a coordinated multisectoral One Health approach.
In response to the COVID-19 outbreak, this guidance provides information on infection and prevention control (IPC) for older people, their friends and families, carers, and healthcare providers. Anyone who manages, works, volunteers or provides care at any type of facilities where older people recei...
The WHO COVID-19 Clinical management: living guidance contains the Organization’s most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal care of COVID-19 patients throughout their entire illness is ...
Updated 2022. This guide addresses the care pathway from presentation of the patient to a health facility to patient discharge. It considers different levels of disease severity, from asymptomatic individuals to critically ill patients. Accounting f...
This document provides up-to-date guidance on laboratory studies as well as smallscale (semi-field) and large-scale field trials to assess the efficacy and determine field
application rates of new molluscicide products for control of schistosomiasis.
Guidelines for Critical Care of Seriously Ill Adult Patients with Coronavirus (COVID-19) in the Americas
recommended
Short Version
This clinical practice guideline was developed in order to provide recommendations for the management of critically ill adult patients with COVID-19 in intensive care units (ICUs).
WHO estimates that in 2015, 257 million people were living with chronic hepatitis B virus (HBV) infection worldwide, and that 900 000 died from HBV infection, mostly through the development of cirrhosis and hepatocellular carcinoma. Worldwide, the majority of persons with chronic hepatitis B infecti...
Just about everyone has experienced the joy that a healthy newborn child brings to parents, families and communities. But the arrival of a newborn who is small or sick often results in immediate worry and sadness. When the infant is at high risk of death or disability, these concerns can be a tremen...
WHO published guidance for clinicians and health care decision-makers on the use of corticosteroids in patients with COVID-19.
We recommend systemic corticosteroids for the treatment of patients with severe and critical COVID-19. We suggest not t...
5 Nov. 2020
The policy brief provides a concise summary of information and considerations to ensure optimal management of influenza during the COVID-19 pandemic. It includes a list of technical guidance and other resources to assist policy makers with monitoring the situation, preventing seasonal i...
HIV-1 drug resistance (HIVDR) genotyping is an essential component of the WHO global HIVDR surveillance strategy. Plasma “gold standard” specimen type for HIVDR genotyping, but its use may not be feasible in rural, remote areas in low- and middle-income countries, since preparing and storing it ...
This document provides guidance on how to implement contact screening and chemoprophylaxis with single-dose rifampicin. The contents are logically ordered: counselling and obtaining consent, identification and listing of index case, listing of contacts, tracing of contacts, screening of contacts, ad...
